Pneumococcal Disease
According to F883, Immunizations for pneumococcal pneumonia the requirements have five aspects:
- The resident is provided education regarding the benefits and potential side effects of the vaccination
- The facility must offer each resident pneumococcal immunizations unless the immunization is medically contraindicated, ore the resident’s immunization status is current
- The resident, or resident’s legal representative, has the right to refuse the vaccinations
- Each eligible resident is administered the pneumococcal vaccine (unless refused or contraindicated or the resident has already been immunized)
- The facility must document that education was provided and that the resident either received the vaccine or, if not received, that the vaccine was refused or medically contraindicated or the resident had already been immunized
Make sure your facility policy includes all five requirements and that the resident’s medical record documents patient education, offering the vaccine, administering the vaccine.
Two pneumococcal vaccines are recommended for adults: PCV13, Prevnar13 and PPSV23, Pneumovax 23. One dose of PCV13 is recommended for adults 65 years and older who have not previously received PCV13. For patients who have not received any pneumococcal vaccine or with unknown vaccination history, give 1 dose of PCV13, and administer 1 dose of PPSV23 at least 1 year later. Once a dose of PPSV23 is given at age 65 or older, no additional doses of PPSV23 should be administered. For those who have previously received 1 dose of PPSV23 and no doses of PCV13 administer 1 dose of PCV13 at least 1 year after dose of PPSV23. The CDC has excellent resources and educational materials regarding adults and pneumococcal disease.
EDUCATIONAL MATERIALS ON PNEUMOCOCCAL VACCINE, BENEFITS & SIDE EFFECTS
PCV13 VACCINE INFORMATION SHEET
PCV13 VACCINE INFORMATION SHEET (SPANISH)
PPSV23 VACCINE INFORMATION SHEET
